RK-287107 is primarily utilized in the field of oncology research, where it serves as a potent inhibitor targeting specific kinases involved in cancer cell proliferation. Its application is significant in studying the mechanisms of tumor growth and in the development of targeted therapies. Researchers employ RK-287107 to explore its efficacy in halting the progression of various cancers, particularly those resistant to conventional treatments. Additionally, it is used in preclinical studies to assess its potential as a therapeutic agent, focusing on its ability to selectively inhibit cancer cells while minimizing damage to healthy tissues. This compound is also valuable in understanding signal transduction pathways and identifying biomarkers for personalized cancer treatment strategies.